Differential impact of cytoplasmic vs. nuclear RAD51 expression on breast cancer progression and patient prognosis-Reference-Cited by-同舟云学术

Differential impact of cytoplasmic vs. nuclear RAD51 expression on breast cancer progression and patient prognosis

Author:

Wang Yen-Yun¹,Cheng Kuang-Hung²,Hung Amos³,Lo Steven⁴,Chen Pang-Yu³,Wu Yi-Chia⁵,Hou Ming-Feng⁶,Yuan Shyng-Shiou⁷

Affiliation:

1. School of Dentistry, College of Dental Medicine, Kaohsiung Medical University Hospital, Kaohsiung 807, Taiwan, R.O.C.

2. Institute of Biomedical Sciences, National Sun Yat‑Sen University, Kaohsiung 804, Taiwan, R.O.C.

3. Graduate Institute of Medicine, College of Medicine, Kaohsiung Medical University, Kaohsiung 807, Taiwan, R.O.C.

4. College of Medical, Veterinary and Life Sciences, University of Glasgow, Glasgow G12 8QQ, UK

5. Division of Plastic Surgery, Department of Surgery, Kaohsiung Medical University, Kaohsiung 807, Taiwan, R.O.C.

6. Division of Breast Oncology and Surgery, Department of Surgery, Kaohsiung Medical University, Kaohsiung 807, Taiwan, R.O.C.

7. Drug Development and Value Creation Research Center, Kaohsiung Medical University Hospital, Kaohsiung 807, Taiwan, R.O.C.

Publisher

Spandidos Publications

Subject

Cancer Research,Oncology

Reference57 articles.

3. Breast cancer treatment;Trayes;Am Fam Physician,2021